IMRT 2018

Shots to take home

IMRT in GI tumors has a clinical benefit in terms of toxicity

IMRT with IGRT offers an extraordinary choice for dose escalation without compromising healthy tissues

Dose escalation increases the local control and the pathological response, with at least, benefits in DFS.

SBRT in a neoadjuvant setting wolud probably bring more opportunities of cure in pancreatic patients

SBRT is an excellent local treatment alternative for liver metastases